USPTO serial 79448278
GRAFTR3
Reviewed by CopyMark Law Group
Status 681
- Filing date
- Status date
- Registration date
- —
- Examiner
- HARMON, RAYMOND E
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with GRAFTR3?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Gregory M. Krakau
Gregory M. Krakau Krakau Law, P.C.100 Pine Street, Suite 1250San Francisco, CA 94111United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medical and pharmaceutical preparations for use in bone repair and bone regeneration; bone void filling compositions comprised of biological materials for medical use; bioactive and osteoconductive materials for medical use, namely, bone void fillers comprised of biological materials; resorbable materials for filling bone defects for medical use, namely, bone void fillers comprised of biological materials; calcium phosphate-based preparations for medical use, namely, bone void fillers comprised of natural materials; freeze dried medical preparations in the nature of bone void fillers comprised of biological materials for reconstructive and orthopaedic purposes; medical preparations in the nature of bone void fillers comprised of natural materials supplied in powder form for reconstitution prior to clinical application; pharmaceutical preparations for promoting bone remodelling and bone healing; medical preparations in the nature of bone void fillers comprised of natural materials for use in orthopaedic, trauma, dental, maxillofacial and reconstructive procedures | ACTIVE | — |
| 010 | Medical and surgical devices and implants, namely, surgical and medical implant devices composed of artificial materials; bone void fillers consisting primarily of synthetic materials and also incorporating biological materials; resorbable bone substitutes; bone substitutes, namely, osteoconductive and bioactive bone substitute materials; medical devices for promoting bone regeneration and bone remodelling; implantable biomaterials in the nature of artificial biomaterials for augmentation of bone and tissue for medical purposes for the treatment of bone defects; microporous and macroporous ceramic medical implants in the nature of bone implants of artificial ceramic materials; biphasic calcium phosphate ceramic implants in the nature of bone implants of artificial ceramic materials; implantable calcium phosphate-based bone substitutes; resorbable implantable scaffolds comprising artificial materials for bone tissue regeneration; freeze-dried medical devices for implantation in the nature of bone implants of artificial materials; medical devices in the nature of bone void fillers comprised of synthetic materials supplied in powder form for reconstitution prior to implantation; medical devices in the nature of bone void fillers comprised of synthetic materials for orthopaedic, trauma, spinal, maxillofacial, dental and reconstructive surgery; surgical implants incorporating polymer binders of pharmaceutical grade; mouldable and injectable bone substitute materials for clinical use; medical devices in the nature of bone void fillers comprised of synthetic materials progressively resorbed and replaced by new bone tissue during healing | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 1, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 1, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 1, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 1, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 17, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 28, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 28, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 22, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 21, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 9, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 23, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 23, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 16, 2026 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |